Research map: Prise en charge de la GVH chronique pulmonaire en 2025, indication de la transplantation pulmonaire (SFGM-TC)
Back to the article
Papers in this map
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
· Madan Jagasia · 2014 · 5502 citations · Cited by this paper
Lymphome cérébral primitif : expérience de treize ans d’un service d’hématologie et oncologie pédiatrique à Casablanca
· 2026 · Related
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
· Talmadge E. King · 2014 · 4057 citations · Cited by this paper
Ours redaction EDB
· 2026 · Related
A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation
· David Weill · 2014 · 1341 citations · Cited by this paper
ONCONNECTE À L’EMPLOI, retour d’expérience après trois ans de mise en place d’un programme de préparation à la reprise d’une activité professionnelle après un cancer en Franche-Comté
· 2026 · Related
Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation
· Lorriana E. Leard · 2021 · 801 citations · Cited by this paper
Le poids de la chirurgie oncologique féminine au Niger : entre diagnostic tardif et l’inaccessibilité à la thérapie adjuvante
· 2026 · Related
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
· Mary E.D. Flowers · 2011 · 697 citations · Cited by this paper
Toxicity of NTRK inhibitors: A clinical overview
· 2026 · Related
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease
· Robert Zeiser · 2021 · 534 citations · Cited by this paper
Sommaire
· 2026 · Related
Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report
· Stephanie J. Lee · 2015 · 434 citations · Cited by this paper
Les critères d’admission en réanimation des patients ayant un cancer : le point de vue du réanimateur et de l’oncologue
· 2026 · Related
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study
· Corey S. Cutler · 2021 · 353 citations · Cited by this paper
Ours redaction EDB
· 2026 · Related
Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
· Olaf Penack · 2024 · 259 citations · Cited by this paper
Ré-irradiation : un nouveau paradigme thérapeutique en cancérologie
· 2026 · Related
Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation
· Kirsten M. Williams · 2015 · 218 citations · Cited by this paper
Qui réfèrent les patients atteints de myélome multiple en hématologie-oncologie : une étude rétrospective à l’Hôtel-Dieu de France
· 2026 · Related
ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease
· Madan Jagasia · 2021 · 195 citations · Cited by this paper
Pleuroparenchymal Fibroelastosis. A Review of Clinical, Radiological, and Pathological Characteristics
· Felix Chua · 2019 · 180 citations · Cited by this paper
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report
· Carrie Lynn Kitko · 2021 · 177 citations · Cited by this paper
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease
· Daniel Wolff · 2024 · 153 citations · Cited by this paper
Effect of Azithromycin on Airflow Decline–Free Survival After Allogeneic Hematopoietic Stem Cell Transplant
· Anne Bergeron · 2017 · 124 citations · Cited by this paper
Budesonide/Formoterol for Bronchiolitis Obliterans after Hematopoietic Stem Cell Transplantation
· Anne Bergeron · 2015 · 119 citations · Cited by this paper
Ateliers d’harmonisation des pratiques de la SFGM-TC
· Rachel Tipton · 2016 · 118 citations · Cited by this paper
Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation
· Anne Bergeron · 2018 · 116 citations · Cited by this paper
Axatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study
· Carrie Lynn Kitko · 2022 · 103 citations · Cited by this paper
Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant
· Guang‐Shing Cheng · 2016 · 99 citations · Cited by this paper
Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis
· Anne Bergeron · 2012 · 96 citations · Cited by this paper
Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT
· Catherine Lucid · 2010 · 87 citations · Cited by this paper
Extracorporeal photopheresis for chronic graft-versus-host disease: a systematic review and meta-analysis
· Mohsin Ilyas Malik · 2014 · 67 citations · Cited by this paper
Late-onset noninfectious interstitial lung disease after allogeneic hematopoietic stem cell transplantation
· Frédéric Schlemmer · 2014 · 66 citations · Cited by this paper
Effects of Azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT—a randomized double-blinded placebo-controlled study
· David Chi-Leung Lam · 2011 · 66 citations · Cited by this paper
Soluble Tumor Necrosis Factor Receptor: Enbrel (Etanercept) for Subacute Pulmonary Dysfunction Following Allogeneic Stem Cell Transplantation
· Gregory Anthony Yanik · 2011 · 66 citations · Cited by this paper
Clinical response to belumosudil in bronchiolitis obliterans syndrome: a combined analysis from 2 prospective trials
· Zachariah Michael DeFilipp · 2022 · 66 citations · Cited by this paper
Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study
· David Bernard Miklos · 2023 · 66 citations · Cited by this paper
Predictive Value of Bronchiolitis Obliterans Syndrome Stage 0p in Chronic Graft-versus-Host Disease of the Lung
· Sameem M. Abedin · 2015 · 64 citations · Cited by this paper
Source: OpenAlex (CC0)